Evidence map›Paper›PMID 30092059›Full record

ArticlePLoS neglected tropical diseases2018

Patients with cystic echinococcosis in the three national referral centers of Mongolia: A model for CE management assessment.

Bolor Bold, Jan Hattendorf, Agiimaa Shagj, Bayar Tserendovdon, Tsendjav Ayushkhuu, Amgalan Luvsandorj, Jakob Zinsstag, Thomas Junghanss

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bolor BoldDepartment of Epidemiology, National Center for Zoonotic Disease, 20th Khoroo, Songinokhairkhan district, Ulaanbaatar, Mongolia.ORCID 0000-0002-7284-2288
Jan HattendorfEpidemiology and Public Health Department, Swiss Tropical and Public Health Institute, Basle, Switzerland.
Agiimaa ShagjDepartment of Epidemiology, National Center for Zoonotic Disease, 20th Khoroo, Songinokhairkhan district, Ulaanbaatar, Mongolia.
Bayar TserendovdonDepartment of Epidemiology, National Center for Zoonotic Disease, 20th Khoroo, Songinokhairkhan district, Ulaanbaatar, Mongolia.
Tsendjav AyushkhuuDepartment of General Surgery, National Center for Maternal and Child Health, Bayangol district, Ulaanbaatar, Mongolia.
Amgalan LuvsandorjDepartment of General Surgery, First Central Hospital, Sukhbaatar district, Ulaanbaatar, Mongolia.
Jakob ZinsstagEpidemiology and Public Health Department, Swiss Tropical and Public Health Institute, Basle, Switzerland.
Thomas JunghanssSection Clinical Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-9229-0193

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMongolia is one of the endemic countries for cystic echinococcosis (CE), a zoonotic disease caused by the larval stage of Echinococcus granulosus. The goal of this study is to describe the current clinical management of CE in Mongolia, to capture the distribution of cyst stages of patients treated, and to contrast current practice with WHO-IWGE expert consensus.

methodsHospital records of CE patients treated between 2008 and 2015 at the three state hospitals and fulfilling the inclusion criterion 'discharge diagnosis CE' (ICD 10 code B.67.0-67.9) were reviewed. Demographical, geographical, clinical and ultrasonography (US) data were extracted and analyzed. The annual surgical incidence was estimated. The digital copies of US cyst images were independently staged by three international experts following the WHO CE cyst classification to determine the proportions of patients which ideally would have been assigned to the WHO recommended treatment modalities surgery, percutaneous, medical (benzimidazole) treatment and watch & wait.

resultsA total of 290 patient records fulfilled the inclusion criteria of the study. 45.7% of patients were below 15 years of age. 73.7% of CE cysts were located in abdominal organs, predominantly liver. US images of 84 patients were staged and assessed for interrater-agreement. The average raw agreement was 77.2%. Unweighted Kappa coefficient and weighted Kappa was 0.57 and 0.59, respectively. Mean proportions of images judged as stages CE1, CE2, CE3a, CE3b, CE4 and CL were 0.59, 0.01, 0.19, 0.08, 0.03 and 0.11, respectively. 40 cysts met the inclusion criteria of treatment modality analysis. The mean proportions of cases with a single cyst assigned to medical, percutaneous treatment, surgery and watch & wait were 52.5% (95% CI 42-65), 25.8% (95% CI 15-30), 5.1% (95% CI 0-10) and 3.3% (95% CI 0-10), respectively. 13.3% (95% CI 5-25) of cysts were staged as CL and therefore assigned to further diagnostic requirement.

conclusionWHO CE cyst classification and WHO-IWGE expert consensus on clinical CE management is not implemented in Mongolia. This results in exclusively surgical treatment, an unnecessary high risk approach for the majority of patients who could receive medical, percutaneous treatment or observation (watch & wait). Introduction of WHO-IWGE expert consensus and training in ultrasound CE cyst staging would be highly beneficial for patients and the health care services.

Indexed as

Clinical ProtocolsAdolescentAdultAlbendazoleAnthelminticsEchinococcosis, HepaticFemaleHumansMaleMiddle AgedMongoliaPublic HealthRisk FactorsYoung AdultAlbendazoleAnthelmintics

Identifiers

PMID30092059
PMCPMC6168150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.